Although congenital heart disease is one of the most common birth defects, its complexity has made the accumulation of an evidence base a challenge. The IMPACT registry, which stands for improving pediatric and adult congenital treatments, has been created to fill this information gap, and it is hoped that these data will provide clinical evidence to help guide treatment for pediatric heart disease. Dr. Gerard Martin, senior vice president for the Center for Heart, Lung and Kidney Disease and co-director of the Children’s National Heart Institute at Children’s National Medical Center, discusses how the IMPACT registry might help improve quality outcomes for our younger patients with congenital heart disease. Dr. Janet Wright hosts.
ReachMD
Be part of the knowledge.™Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?
Pediatric Heart Disease: The Need for More Rigorous Clinical Evidence
Restart
Resume
Share this program on:
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Presenters
Comments
Recommended
Details
Presenters
Comments
Recommended
Overview
Although congenital heart disease is one of the most common birth defects, its complexity has made the accumulation of an evidence base a challenge. The IMPACT registry, which stands for improving pediatric and adult congenital treatments, has been created to fill this information gap, and it is hoped that these data will provide clinical evidence to help guide treatment for pediatric heart disease. Dr. Gerard Martin, senior vice president for the Center for Heart, Lung and Kidney Disease and co-director of the Children’s National Heart Institute at Children’s National Medical Center, discusses how the IMPACT registry might help improve quality outcomes for our younger patients with congenital heart disease. Dr. Janet Wright hosts.
Presenters
Facebook Comments